{"transactions":[{"id":3363214,"issuer":{"id":7143,"kind":"organization","name":"Cineverse Corp.","symbol":"CNVS"},"owners":[{"id":153655,"kind":"organization","name":"Bison Capital Holding Co Ltd","position":1,"cik":"0001593415","reported_name":"Bison Capital Holding Co Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-11-21T22:46:47.000Z","date":"2019-08-02","kind":"purchase","acquired":true,"shares":1900000,"price":2850000,"value":5415000000000.0,"ownership":{"direct":false,"nature":"By holding"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Representing 1,900,000 shares of Class A Common Stock originally issued to BEMG at $1.50 per share pursuant to a purchase agreement between the Company and BEMG dated August 2, 2019 and later transferred by BEMG to BEI pursuant to a share transfer agreement among BEMG and BEI dated October 24, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bison Capital Holding Company Limited owns 100% equity interest of Bison Entertainment and Media Group (\"BEMG\") who then holds 100% equity interest of Bison Entertainment Investment Limited (\"BEI\").,."}],"balance_after":23566667,"source":{"system":"sec-edgar","filing":"0001213900-19-024376","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1173204/000121390019024376/ownership.xml","form_type":"4"}},{"id":3363213,"issuer":{"id":7143,"kind":"organization","name":"Cineverse Corp.","symbol":"CNVS"},"owners":[{"id":153655,"kind":"organization","name":"Bison Capital Holding Co Ltd","position":1,"cik":"0001593415","reported_name":"Bison Capital Holding Co Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-11-21T22:46:47.000Z","date":"2019-07-09","kind":"purchase","acquired":true,"shares":2000000,"price":4500000,"value":9000000000000.0,"ownership":{"direct":false,"nature":"By holding"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Representing 2,000, 000 shares of Class A Common Stock originally issued to BEMG at $1.50 per share pursuant to a purchase agreement between the Company and BEMG dated July 9, 2019 and transferred by BEMG to BEI pursuant to a share transfer agreement among BEMG and BEI dated October 24, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bison Capital Holding Company Limited owns 100% equity interest of Bison Entertainment and Media Group (\"BEMG\") who then holds 100% equity interest of Bison Entertainment Investment Limited (\"BEI\").,."}],"balance_after":21666667,"source":{"system":"sec-edgar","filing":"0001213900-19-024376","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1173204/000121390019024376/ownership.xml","form_type":"4"}},{"id":3516419,"issuer":{"id":157082,"kind":"organization","name":"XYNOMIC PHARMACEUTICALS HOLDINGS, INC.","symbol":"XYN"},"owners":[{"id":153655,"kind":"organization","name":"Bison Capital Holding Co Ltd","position":1,"cik":"0001593415","reported_name":"Bison Capital Holding Co Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% more owner"}}],"security":"Warrants","published_at":"2019-05-21T13:58:01.000Z","date":"2019-05-15","kind":"purchase","acquired":true,"shares":25000,"price":11.5,"value":287500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the closing of a business combination with Xynomic Pharmaceuticals, Inc., Bison Capital Holding Company Limited, a Cayman Islands company (\"Bison Capital\"), purchased 13,793 shares (the \"Backstop Shares\") of common stock of Bison Capital Acquisition Corp., a Delaware corporation (now known as Xynomic Pharmaceuticals Holdings, Inc., the \"Company\"), par value $0.001 per share pursuant to a Backstop and Subscription Agreement dated May 1, 2019 between the Company and Yiling Mark Xu and converted its $500,000 promissory notes issued by the Company into 55,000 common shares and 25,000 warrants, each exercisable to purchase one share of common stock at $11.50 per whole share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of a business combination with Xynomic Pharmaceuticals, Inc., Bison Capital Holding Company Limited, a Cayman Islands company (\"Bison Capital\"), purchased 13,793 shares (the \"Backstop Shares\") of common stock of Bison Capital Acquisition Corp., a Delaware corporation (now known as Xynomic Pharmaceuticals Holdings, Inc., the \"Company\"), par value $0.001 per share pursuant to a Backstop and Subscription Agreement dated May 1, 2019 between the Company and Yiling Mark Xu and converted its $500,000 promissory notes issued by the Company into 55,000 common shares and 25,000 warrants, each exercisable to purchase one share of common stock at $11.50 per whole share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the promissory note and warrant agreement, each unit consists of one share; each whole warrant entitles the holder to one common share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the promissory note and warrant agreement, each unit consists of one share; each whole warrant entitles the holder to one common share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Pursuant to the promissory note and warrant agreement, each unit consists of one share; each whole warrant entitles the holder to one common share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Fengyun Jiang, who has 100% ownership interest in Bison Capital and is Peixin Xu's spouse, has voting and dispositive power over the shares held by such entity. Mr. Xu was the Chairman of the Company but resigned at the closing of a business combination, effective May 15, 2019."}],"balance_after":225937,"derivative":{"exercise_price":11.5,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-19-009295","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593415/000121390019009295/ownership.xml","form_type":"4"}},{"id":3516418,"issuer":{"id":157082,"kind":"organization","name":"XYNOMIC PHARMACEUTICALS HOLDINGS, INC.","symbol":"XYN"},"owners":[{"id":153655,"kind":"organization","name":"Bison Capital Holding Co Ltd","position":1,"cik":"0001593415","reported_name":"Bison Capital Holding Co Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% more owner"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-05-21T13:58:01.000Z","date":"2019-05-15","kind":"purchase","acquired":true,"shares":108980,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the closing of a business combination with Xynomic Pharmaceuticals, Inc., Bison Capital Holding Company Limited, a Cayman Islands company (\"Bison Capital\"), purchased 13,793 shares (the \"Backstop Shares\") of common stock of Bison Capital Acquisition Corp., a Delaware corporation (now known as Xynomic Pharmaceuticals Holdings, Inc., the \"Company\"), par value $0.001 per share pursuant to a Backstop and Subscription Agreement dated May 1, 2019 between the Company and Yiling Mark Xu and converted its $500,000 promissory notes issued by the Company into 55,000 common shares and 25,000 warrants, each exercisable to purchase one share of common stock at $11.50 per whole share."},{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the closing of a business combination with Xynomic Pharmaceuticals, Inc., Bison Capital Holding Company Limited, a Cayman Islands company (\"Bison Capital\"), purchased 13,793 shares (the \"Backstop Shares\") of common stock of Bison Capital Acquisition Corp., a Delaware corporation (now known as Xynomic Pharmaceuticals Holdings, Inc., the \"Company\"), par value $0.001 per share pursuant to a Backstop and Subscription Agreement dated May 1, 2019 between the Company and Yiling Mark Xu and converted its $500,000 promissory notes issued by the Company into 55,000 common shares and 25,000 warrants, each exercisable to purchase one share of common stock at $11.50 per whole share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of a business combination with Xynomic Pharmaceuticals, Inc., Bison Capital Holding Company Limited, a Cayman Islands company (\"Bison Capital\"), purchased 13,793 shares (the \"Backstop Shares\") of common stock of Bison Capital Acquisition Corp., a Delaware corporation (now known as Xynomic Pharmaceuticals Holdings, Inc., the \"Company\"), par value $0.001 per share pursuant to a Backstop and Subscription Agreement dated May 1, 2019 between the Company and Yiling Mark Xu and converted its $500,000 promissory notes issued by the Company into 55,000 common shares and 25,000 warrants, each exercisable to purchase one share of common stock at $11.50 per whole share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Fengyun Jiang, who has 100% ownership interest in Bison Capital and is Peixin Xu's spouse, has voting and dispositive power over the shares held by such entity. Mr. Xu was the Chairman of the Company but resigned at the closing of a business combination, effective May 15, 2019."}],"balance_after":1628580,"source":{"system":"sec-edgar","filing":"0001213900-19-009295","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593415/000121390019009295/ownership.xml","form_type":"4"}},{"id":4117385,"issuer":{"id":7143,"kind":"organization","name":"Cineverse Corp.","symbol":"CNVS"},"owners":[{"id":153656,"kind":"organization","name":"Bison Entertainment & Media Group","position":1,"cik":"0001722103","reported_name":"Bison Entertainment & Media Group","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153655,"kind":"organization","name":"Bison Capital Holding Co Ltd","position":2,"cik":"0001593415","reported_name":"Bison Capital Holding Co Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153658,"kind":"person","name":"Jiang Fengyun","position":3,"cik":"0001705836","reported_name":"Jiang Fengyun","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2018-01-02T17:29:38.000Z","date":"2017-12-29","kind":"other","acquired":true,"shares":1400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Warrants held by BEMG.  The warrants to purchase up to 1,400,000 shares of Class A Common Stock of the Company were issued by the Company to BEMG on December 29, 2017 in connection with its agreement to make a loan to the Company in the principal amount of US$10,000,000.00."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Warrants held by BEMG.  The warrants to purchase up to 1,400,000 shares of Class A Common Stock of the Company were issued by the Company to BEMG on December 29, 2017 in connection with its agreement to make a loan to the Company in the principal amount of US$10,000,000.00."}],"balance_after":1400000,"derivative":{"exercise_price":1.8,"exercise_date":"2017-12-29","expiration_date":"2022-12-29","underlying":"Class A Common Stock","underlying_shares":1400000},"source":{"system":"sec-edgar","filing":"0000899243-18-000035","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1173204/000089924318000035/doc4.xml","form_type":"4"}},{"id":4270900,"issuer":{"id":157082,"kind":"organization","name":"XYNOMIC PHARMACEUTICALS HOLDINGS, INC.","symbol":"XYN"},"owners":[{"id":153655,"kind":"organization","name":"Bison Capital Holding Co Ltd","position":1,"cik":"0001593415","reported_name":"Bison Capital Holding Co Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Sponsor"}}],"security":"Warrants","published_at":"2017-06-28T17:09:04.000Z","date":"2017-06-28","kind":"purchase","acquired":true,"shares":19688,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company (\"Bison Capital\"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the \"Company\"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the \"Unit Subscription Agreement\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company (\"Bison Capital\"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the \"Company\"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the \"Unit Subscription Agreement\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Unit Subscription Agreement, each unit consists of one share, one right and one-half of one warrant. Each right entitles the holder to receive one-tenth of one share upon consummation of the Company's initial business combination, expiring at the 5th anniversary of the business combination. Each whole warrant entitles the holder to one Ordinary Share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Unit Subscription Agreement, each unit consists of one share, one right and one-half of one warrant. Each right entitles the holder to receive one-tenth of one share upon consummation of the Company's initial business combination, expiring at the 5th anniversary of the business combination. Each whole warrant entitles the holder to one Ordinary Share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Pursuant to the Unit Subscription Agreement, each unit consists of one share, one right and one-half of one warrant. Each right entitles the holder to receive one-tenth of one share upon consummation of the Company's initial business combination, expiring at the 5th anniversary of the business combination. Each whole warrant entitles the holder to one Ordinary Share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination."}],"balance_after":200938,"derivative":{"exercise_price":11.5,"underlying":"Ordinary share","underlying_shares":19688},"source":{"system":"sec-edgar","filing":"0001213900-17-006910","document":"f4062817bison_bisoncapital.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1593415/000121390017006910/f4062817bison_bisoncapital.xml","form_type":"4"}},{"id":4270899,"issuer":{"id":157082,"kind":"organization","name":"XYNOMIC PHARMACEUTICALS HOLDINGS, INC.","symbol":"XYN"},"owners":[{"id":153655,"kind":"organization","name":"Bison Capital Holding Co Ltd","position":1,"cik":"0001593415","reported_name":"Bison Capital Holding Co Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Sponsor"}}],"security":"Rights","published_at":"2017-06-28T17:09:04.000Z","date":"2017-06-28","kind":"purchase","acquired":true,"shares":39375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company (\"Bison Capital\"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the \"Company\"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the \"Unit Subscription Agreement\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company (\"Bison Capital\"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the \"Company\"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the \"Unit Subscription Agreement\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Unit Subscription Agreement, each unit consists of one share, one right and one-half of one warrant. Each right entitles the holder to receive one-tenth of one share upon consummation of the Company's initial business combination, expiring at the 5th anniversary of the business combination. Each whole warrant entitles the holder to one Ordinary Share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Unit Subscription Agreement, each unit consists of one share, one right and one-half of one warrant. Each right entitles the holder to receive one-tenth of one share upon consummation of the Company's initial business combination, expiring at the 5th anniversary of the business combination. Each whole warrant entitles the holder to one Ordinary Share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Pursuant to the Unit Subscription Agreement, each unit consists of one share, one right and one-half of one warrant. Each right entitles the holder to receive one-tenth of one share upon consummation of the Company's initial business combination, expiring at the 5th anniversary of the business combination. Each whole warrant entitles the holder to one Ordinary Share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination."}],"balance_after":401875,"derivative":{"exercise_price":0,"underlying":"Ordinary share","underlying_shares":3937},"source":{"system":"sec-edgar","filing":"0001213900-17-006910","document":"f4062817bison_bisoncapital.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593415/000121390017006910/f4062817bison_bisoncapital.xml","form_type":"4"}},{"id":4270898,"issuer":{"id":157082,"kind":"organization","name":"XYNOMIC PHARMACEUTICALS HOLDINGS, INC.","symbol":"XYN"},"owners":[{"id":153655,"kind":"organization","name":"Bison Capital Holding Co Ltd","position":1,"cik":"0001593415","reported_name":"Bison Capital Holding Co Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Sponsor"}}],"security":"Ordinary share, no par value","published_at":"2017-06-28T17:09:04.000Z","date":"2017-06-28","kind":"purchase","acquired":true,"shares":39375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company (\"Bison Capital\"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the \"Company\"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the \"Unit Subscription Agreement\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company (\"Bison Capital\"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the \"Company\"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the \"Unit Subscription Agreement\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company (\"Bison Capital\"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the \"Company\"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the \"Unit Subscription Agreement\")."}],"balance_after":1519600,"source":{"system":"sec-edgar","filing":"0001213900-17-006910","document":"f4062817bison_bisoncapital.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593415/000121390017006910/f4062817bison_bisoncapital.xml","form_type":"4"}}]}